# Phase 1B validation and readiness

Phase 1B is complete at the foundational-notes level as of 2026-09-11. Completion reflects a conceptual review and document checks, not just file existence. These are research-document checks, not biological experiments or a certification of learner mastery.

## Conceptual consistency review

| Check | Mechanistic answer retained in the notes | Result |
|---|---|---|
| Same genome, different programs | Regulatory element usage, chromatin, TF activity and post-transcriptional/protein controls affect output | Consistent |
| Phase 1A connection | Regulation affects DNA readout and downstream processes; protein feedback does not reverse sequence transfer | Consistent after documented corrections |
| TF expression versus activity | RNA does not establish protein amount, localization, modification, binding or effect | Explicit in 05 and 12 |
| Accessibility versus expression | Probe-dependent opportunity is distinct from productive transcription and RNA accumulation | Explicit in 06-07 |
| Enhancer-gene causality | Peak, motif, contact, reporter and endogenous perturbation have different meanings | Explicit in 03 and 11 |
| Methylation context | Promoter, gene-body and distal-site contexts differ; coverage and 5hmC ambiguity matter | Explicit in 09 |
| Histone marks | Four requested marks have contextual associations; poised does not guarantee future activation | Explicit in 10 |
| Inferred versus experimental links | Value encoding and evidence provenance are independent fields; directness is separately assessed | Explicit in 11-12 and data bridge |
| Development | Stage, changing molecular state and ancestry are distinct; supplied labels remain unverified | Explicit in 14 |
| Representation neutrality | Multiple forms listed without selecting, constructing or benchmarking one | Preserved |

### Worked comprehension checks

1. **Accessible promoter, no detected RNA:** compatible with missing activation, nonproductive transcription, timing or measurement limitations. Do not relabel the accessibility measurement as incorrect solely because RNA is zero. See [07](07_CHROMATIN_ACCESSIBILITY.md).
2. **High TF RNA, low target output:** does not disprove regulation; protein availability/activity and target context remain unknown. See [05](05_TRANSCRIPTION_FACTORS.md).
3. **Distal contact, no perturbation response:** contact and effect are distinct; the response also depends on the perturbation, controls, context and measurement sensitivity. See [11](11_ENHANCER_PROMOTER_INTERACTIONS.md).
4. **Methylation fraction from zero coverage:** undefined, represented as missing; not 0% methylated. See [09](09_DNA_METHYLATION.md).
5. **Matching RNA and ATAC row counts:** insufficient to establish paired cells; require observation-level provenance. See [BIOLOGY_TO_DATA.md](BIOLOGY_TO_DATA.md).
6. **Similar E11/E13 vectors:** neither ancestry nor developmental time is established from similarity. See [14](14_DEVELOPMENTAL_REGULATION_BRIDGE.md).

These answers were checked against the mechanisms and evidence locators in the linked notes. They do not resolve any dataset-specific hypothesis.

## Files and structural checks

- All 14 numbered topic files plus CONCEPT_MAP.md and BIOLOGY_TO_DATA.md exist.
- Every numbered topic has nonempty A-H sections.
- SOURCES.md indexes the 24 new, actually used sources; 24 biological source records are under 03_papers/.
- papers.csv has 38 rows and 15 columns, unique paper IDs, no duplicate known DOI, no blank/malformed cells, and existing extraction paths.
- Footnote references/definitions and local file links resolve. New Markdown files have no trailing whitespace.
- git diff --check passes.
- Dataset and computational registries and REPRESENTATION_TAXONOMY.md are unchanged.
- No data or executable research code, model, experimental result or disease payload was introduced.

Source identity was checked using publisher or NCBI records and publisher-indexed text. The scope of inspected material is recorded for each source. Some direct links intermittently serve browser challenges or subscription previews; bibliographic resolution is distinct from unrestricted full-text access. No abstract is represented as a review of an uninspected detailed method.

## Phase 1A corrections

The research log preserves the prior completion history and records corrections to seven Phase 1A files:

| Files | Correction |
|---|---|
| 03_GENES.md | Gerstein title/year/venue/DOI and distinction between gene boundaries and associated regulatory DNA |
| 05_TRANSCRIPTION.md | Laehnemann attribution |
| 07_GENE_EXPRESSION.md | Laehnemann attribution; separation of RNA abundance, protein abundance and activity |
| 09_PROTEINS.md | Total abundance versus localization and modification-dependent activity |
| 10_CENTRAL_DOGMA_INTEGRATION.md | Sequence-information transfer versus feedback; study chain versus chemical conversions |
| CONCEPT_MAP.md | Meaning of conceptual arrows, distal regulatory elements and protein feedback |
| BIOLOGY_TO_DATA.md | Laehnemann attribution and Svensson's correct venue |

Supporting publications are preserved in papers.csv and the [source register](SOURCES.md). No new duplicate rows were created for the existing Laehnemann or Svensson sources.

## Graphify status

Both requested executions of graphify . --code-only were attempted:

| Run | Files skipped as non-code | Supported code | Exit status | Outcome |
|---|---:|---:|---:|---|
| Before research | 27 | 0 | 1 | Empty graph; no nodes |
| After research | 68 | 0 | 1 | Empty graph; no nodes |

The second run classified skipped content as 65 documents and 3 papers; those are tool classifications, not bibliography counts. The generated graphify-out/cache/stat-index.json is preserved, untracked. No applicable generated-output ignore policy exists, and no Git policy was introduced.

No code relationships require documentation because no repository code was added. Graphify did not validate the biological conceptual chain and is not cited as scientific evidence.

## Unresolved biological questions

- Which regulatory elements and TFs act in the actual sampled populations?
- Which accessible regions are active, permissive or poised, and at which times?
- Which candidate enhancer-gene relationships have context-matched functional support?
- Which chromatin changes cause, maintain or follow expression changes?
- Which observed states persist through division, and what establishes that memory?
- Do differences among supplied developmental-stage datasets reflect composition, within-lineage changes, anatomy, sampling or technical effects?

Resolving these requires evidence beyond this phase. Dataset technologies, pairing, units, stage conventions, sample relationships and original publications remain unverified.

## Deeper study and readiness for Phase 1C

The foundation supports proceeding to **Cellular Biology and Tissue Organization**: molecular regulation can now be connected to cell organization, function and tissue context without equating assay values with biological identity.

Topics to revisit when relevant include locus-specific enhancer specificity, evidence for epigenetic maintenance, direct TF mechanisms, histone-mark causality, and lineage versus molecular-state evidence. Detailed assay chemistry, single-cell methods, spatial methods, integration, representation learning and benchmarking require later authorization and study.

Phase 1C has not begun. All changes remain local and uncommitted.
